Mann and Magath (1) in 1922 first described the clinical symptoms associated with hypoglycemia, and in 1924 Harris (2) reviewed its relationship to hyperinsulinism. Since then, numerous articles have appeared in the literature reviewing the causes of hypoglycemia, (3-6) describing individual cases and suggesting various surgical and medical methods of management.
Mann and Magath (1) in 1922 first described the clinical symptoms associated with hypoglycemia, and in 1924 Harris (2) reviewed its relationship to hyperinsulinism. Since then, numerous articles have appeared in the literature reviewing the causes of hypoglycemia, (3-6) describing individual cases and suggesting various surgical and medical methods of management.
Although spontaneous hypoglycemia is evidence of abnormal carbohydrate metabolism, this abnormality may be due to a variety of diseases.
The present communication describes three cases of hypoglycemia occurring in one family, and one unrelated case, in which convulsions and profound lowering of the blood glucose were induced by the administration of proteins or amino acids.
We believe this abnormal relationship between amino acids and glucose metabolism has not been previously described, and will be of great interest, not only to the clinician, but also to the biochemist and physiologist investigating carbohydrate and protein metabolism. CASES Case 1. A female infant was admitted to The Hospital for Sick Children, Great Ormond Street on 29th September 1954, at the age of 4 months for investigation of convulsions. Her mother's pregnancy and labor were normal. Her birth weight was 7 lbs. The infant was breast fed for 10 weeks and then given half cream cow's milk feeds with added sugar. At 3 months she began to have generalized convulsions. She had two or three fits every day and these usually occurred about midway between feeds but not after waking in the mornings.
The fits lasted from a few minutes to half-an-hour.
Examination showed a plump 12 lb. 3 oz. infant with no abnormal physical signs. Her mental development was normal for her age. Since her sister (case 2) had convulsions associated with hypoglycemia, fasting blood was taken and this showed blood sugar levels varying from 40 to 60 mg. per 100 ml. The levels of blood sugar before feeds showed a gradual decline throughout the day-the fasting level being around 50 mg. per 100 ml. and by 10 p.m. the level had dropped to around 30 mg. per 100 ml.
An electro-encephalogram, carried out when the blood sugar level was 38 mg. per 100 ml., was normal.
The plasma level of insulin-like activity was estimated by Dr. P. J. Randle (7, cf. 8, 9) and was found to be normal. A high protein low carbohydrate diet (cow's milk with added casein) was then given and she immediately began to have convulsions which occurred at about one hour after each feed. On "Soylac," a soya flour synthetic milk, she had numerous convulsions, her fasting blood sugar was only 20 mg. per 100 ml. and this tended to drop slightly during the day. She was then fed with expressed breast milk, the levels of blood sugar before feeds were higher and the baby was free from fits for the first time. Cow's milk diluted with three parts of water and with added sugar had the same effect. Mixed feeding was started, care being taken to see that no large amount of protein was given without carbohydrate being given at the same time. She has remained well, having about one fit every six weeks. Her mental and physical development are normal.
Case 2. A female infant, elder sister of case 1, was admitted to The Hospital for Sick Children, Great Ormond Street on 30th May 1953 at the age of 2% months.
Her birth weight was 7 lb. 1 oz. and her mother's pregnancy and labor were normal. She was breast fed for two months and then given full cream dried cow's milk feeds. After one week she began having generalized convulsions dating from the time when extra sugar was omitted from her feeds. During the fits she became flushed, sweated, and lost consciousness. She had about twelve fits in the three weeks prior to admission. No history of their relation to feeds could be obtained. Examination showed a small infant who weighed 7 lb. 10 oz. There were no abnormal signs and her mental development was within the normal range for her age. The C.S.F. was normal apart from a sugar value of 25 mg. per 100 ml. An E.E.G. was normal. The fasting blood sugar levels varied from 32 mg. per 100 ml. to 50 mg. per 100 ml. Blood sugar levels just before meals were in the range of 40 to 65 mg. per 100 ml.
A laparotomy was performed; the pancreas was normal in size but rather firm and portions of the tail of the pancreas and of the liver were removed for histological study. There was no evidence of any neoplastic or hyperplastic change in the islets and no significant pathological change in the islet cells except that there was some enlargement, vacuolation and loss of granular dis- Folin and Wu, the third is "true sugar" estimated as described below). His plasma level of insulin-like activity was normal (7, cf. 8 and 9) .
Family history: Cases 1 and 2 are the only children of case 3. There were no still-births or miscarriages. Repeated attempts to trace other members of the father's family have failed. There is no history of epilepsy in the mother's family.
Case 4-was the only child of healthy Cypriot parents. One of the mother's uncles is said to have had fits but no further details could be obtained. He was admitted to The Hospital for Sick Children, Great Ormond Street on 26th March 1952 at the age of 5 months for the investigation of convulsions. His mother's pregnancy and labor were normal. His birth weight was 6 lb. 14 ozs. He was breast fed until he was 3 months old when he was given full cream dried cow's milk feeds with added sugar. When he was 2 months old he began to have fits. At first he went pale without sweating, rolled up his eyes and did not respond to external stimuli. These fits occurred 2 to 3 times daily, usually during a feed, and they lasted about two minutes. Over a period of a few weeks he began to have more frequent and generalized convulsions unrelated to feeds. He was then admitted for further investigation.
Examination showed a large hypotonic infant weighing 12 lb. 2 oz. He did not hold up his head neither did he attempt to grasp an object, nor follow a light. There were no other abnormal signs.
The cerebro-spinal fluid was normal apart from a sugar value of 20 mg. per 100 ml. His fasting blood sugar levels ranged from 17 to 50 mg. per 100 ml. Preprandial blood sugars remained between 35 and 45 mg. per 100 ml.
On 6th January 1953 a laparotomy was carried out
The pancreas appeared large but otherwise normal. The distal two-thirds were removed. There was about four times the normal amount of islet tissue present, this was partly grouped in well formed islets but in addition there were islet cells grouped in strands and small acini infiltrating between the acini of exocrine tissue. There was no evidence of neoplastic change and no increase in interstitial tissue. The majority of cells were ,-cells and a minority were a-cells. A liver biopsy carried out at the same time showed no evidence of glycogen storage disease. The plasma level of insulin-like activity was six times normal before operation, twenty months after operation it was five times normal (7, cf. 8 and 9) . Following operation his fasting blood sugar fell over 3 months from 50 to [25] [26] [27] [28] [29] [30] mg. per 100 ml. He was given cortisone for 8 months and during this time had no fits. Since then he has had only one fit every four to six weeks apart from a period of 2 to 3 months when he had 2 to 3 fits a week. He is given frequent meals and phenobarbitone.
Although his development appeared to be normal until the onset of fits at two months of age, he is now three years and four months old and is grossly retarded. He began to walk with help when two years old, but is still unable to walk unaided. He does not speak, has to be fed and has no control over micturition and defecation.
MATERIALS AND METHODS
The blood sugar concentration was followed in cases 1, 2, 3, and 4 and in normal subjects after feeding glucose, casein, gelatine, leucine, tyrosine, or isovaleric acid and after injecting insulin, glucagon or adrenaline.
L-leucine puriss and L-tyrosine were used as purchased from L. Light & Co. Ltd. They were suspended in a little water or in 3 per cent methylcellulose which was flavored with saccharin and oil of orange and frozen to an "ice cream."
Isovaleric acid, laboratory reagent grade, was dissolved in a slight excess of aqueous sodium bicarbonate solution and chilled.
Casein ("Casilan," Glaxo) and gelatine were suspended in a little water.
Biodeminrolit G (Permutit, Ltd.) was saturated with carbon dioxide and kept in a tightly closed jar.
Sodium tungstate: a 10 per cent aqueous solution was used.
Sulphuric acid: 0.66 N. Alkaline copper reagent (10):
A: CuSO4 5H2O: 2 g., Na2SO4: 18 g., water to 100 ml. B: Na2CO.: 12 g., Rochelle salt 6 g., NaHCO.: 8 g., Na2SO4: 72 g., water to 400 ml. These were mixed in the ratio of one part A to four parts B immediately before use.
FAMILIALI HYPOGLYCEMIA PRECIPITATED BY AMINO ACIDS
Arsenomolybdic acid was prepared by the method of Nelson (11) .
Blood sugar estimation. After an overnight fast (7 to 14 hours) a specimen of capillary blood was collected by finger-prick or heel-prick into a bottle containing fluoride and oxalate. The test-substance was fed, the time taken to swallow it was noted, and blood samples were taken 10, 20, 30, 45, 60, and 90( minutes after all the substance had been ingested.
The blood sugar estimations were carried out as soon as all the blood samples had been collected. Four-tenths ml. of each sample (or less if the blood sample was unusually small) was added from a pipette calibrated "to contain" to 6.8 ml. of water in a centrifuge tube and mixed. Four-tenths ml. of sodium tungstate and 0.4 ml. of sulphuric acid were added to each tube and the contents well shaken. After centrifuging, the supernatant from each tube was shaken with Biodeminrolit G (about 0.75 ml. in volume) for 5 minutes. The sugar in the supernatant was estimated by the alkaline copper arsenomolybdate method and compared with a standard solution of glucose treated similarly (10, 11) . The color intensities were read against the blank in a photo-electric colorimeter using an Ilford 604 filter (X.. = 520 nxu).
Blood amino-acid values. These were determined by the method of West, Wilson, and Eyles (12).
Paper chromatography. For investigating the blood sugars the tungstic acid filtrate, after treatment with Biodeminrolit G, was examined by paper chromatography (13, 14) . Urine was treated with Biodeminrolit G and similarly examined. For amino acid investigation venous blood was collected and the serum passed through a column of Zeo Karb 225 (a sulphonated polystyrene resin). Proteins, sugar, acids and all other non-basic components were washed away with water, and the amino acids desorbed with SM-ammonia solution. The ammonia eluate was evaporated in vacuo and the residue examined by two-dimensional paper chromatography without further treatment. Urinary amino acids were examined by two-dimensional paper chromatography (13) after electrolytic desalting. RESULTS 
AND INTERPRETATION

Glucose tolerance
The glucose tolerance curves for the four subjects are shown in Figure 1 . The values for cases 1 and 2 represent "true blood sugar" (see below) and were determined by the method given above, those for cases 3 and 4 represent "apparent blood sugar" determined by a modification of the method of Folin and Wu (15, 16) . All four show a normal rise and fall, the blood sugar returning to the fasting level within 2% hours with no evidence of an abnormal fall within 5 hours.
Effect of hormones
Glucose insulin tolerance test (17) . Case 2:
Glucose (10 g.) was given by mouth and, simultaneously, 1.0 unit of insulin intravenously. The fasting blood sugar was 28.5 mg. per 100 ml. and rose to 91 mg. per 100 ml. at 30 minutes falling to 38 mg. per 100 ml. at 90 minutes. Case 4: Glucose (19 g.) was given by mouth and 1.1 units of insulin intravenously. The fasting blood sugar was 31 mg. per 100 ml. and rose to 121 mg. per 100 ml., at 30 minutes, falling to 34 mg. at 60 minutes.
Adrenaline tolerance test. Adrenaline (0.2 mg.) was given subcutaneously after an 8-hour fast to cases 1, 2, and 4. The blood sugar level rose in the first half-hour from 27 to 45 mg. per 100 ml. in case 1, from 45 to 140 in case 2 and from 52 to 115 in case 4. The blood sugar was still high after 2 hours (50, 93, and 87 mg. per 100 ml., respectively).
Glucagon. After an 8-hour fast glucagon 2 was given intramuscularly to cases 1 and 4 (7,500 and 10,000 cat units, respectively). In case 1 the blood sugar level rose from 30 to a peak of 94 mg.
per 100 ml. in 15 minutes, followed by a steady fall to 38 mg. per 100 ml. at 90 minutes. In case 4 the blood sugar rose from 31 to 92 mg. per 100 ml. in 30 minutes and fell to 35 mg. per 100 ml. by 2 hours. Case 1 was given 14 gm. of casein over 30 minutes and immediately after this had been ingested 7,500 cat units of glucagon were given by intramuscular injection. The fasting blood sugar was 32 mg. per 100 ml. and after the casein had been given it fell to 19 mg. per 100 ml.
Half-an-hour after the injection of glucagon the blood sugar level had risen to 76.5 mg. per 100 ml. and 2 hours later still it was 90.5 mg. per 100 ml. A.C.T.H. and cortisone. A.C.T.H. gel (10 mg.) was given intramuscularly twice daily for 10 days to case 1. The blood sugar level was higher in the mornings but fell to its previous level later in the day. Although there were no convulsions during this period A.C.T.H. did not cause any striking alteration of blood sugar levels throughout the day. Three weeks later 10 mg. of cortisone was given 5 times daily for 3 days. No effect on the blood sugar levels was noted.
A.C.T.H. (10 mg.) was given by intramuscular injection 6 hourly to case 2 for 6 days and later 100 mg. cortisone was given daily by mouth in divided doses for 11 days. In both instances there was a slight rise in blood sugar levels throughout the day and the patient had no fits.
Cortisone (20 mg.) was given twice daily for 18 days to case 4 and then the dose was increased to 60 mg. daily. After this the fasting blood sugar rose to 40 to 61 mg. per 100 ml. and the levels of blood sugar before feeds varied between 75 and 107 mg. per 100 ml. Before cortisone was given the fasting blood sugar varied from 17 to 50 mg. per 100 ml. and the blood sugar levels ranged from 35 to 45 mg. per 100 ml. throughout the day. The cortisone was given for 8 months and during this time he had no fits.
In cases 1, 2, and 4 there was no evidence of hyper-sensitivity to insulin and the hyperglycemic response to adrenaline and glucagon was normal. Casein did not prevent the hyperglycemic effect of glucagon in case 1.
A.C.T.H. and cortisone were given in too small doses and for too short a period to case 1 for any conclusions to be drawn. In case 2 although there was no striking alteration in blood sugar levels clinical improvement was evident. Cortisone ef- fected an improvement both in the clinical state and in the levels of blood sugar in case 4.
Effect of protein
The effects of feeding casein to three fasting patients are shown in Figure 2 curves the changes in the corresponding blood amino acid concentrations. Figure 3 shows the blood sugar concentrations and the changes in blood amino acid concentration when casein was fed to fasting normal subjects. The method of measuring blood amino acid levels is adequate for changes in level after feeding protein, but cannot measure absolute amino acid concentrations with any accuracy (12) .
FIG. 3. BLOOD SUGAR (-) AND AMINO-NITROGEN RISE (---) OF THREE NORMAL SUBJECTS
The casein had a marked hypoglycemic effect on the three patients, but none on the normal sub- jects, yet the rise in blood amino acids was similar in both groups. The blood amino acid peak coincided in time with the minimum of the blood sugar concentration.
The effect on the blood sugar of feeding a normal subject a test dose of glucose alone and, next day, an equal dose of glucose with casein added is shown in Figure 5 , together with the change of blood amino acid level. In case 1 a test dose of 13 g. casein and 14 g. glucose caused a slight initial rise in the blood sugar level from 47 to 58 mg. per 100 ml. after 10 minutes, followed by a profound fall to 26 mg. per 100 ml. at 20 minutes and 18 mg. per 100 ml. at 45 minutes. The blood sugar rose to 31 mg. per 100 ml. after 60 minutes.
The results of the casein-glucose tests were, however, more variable than the other tests. Gelatine had only a slight hypoglycemic effect on case 1, and tyrosine none at all ( Figure 6 ). The rise in blood amino acids was as rapid after feeding gelatine as after casein.
Effect of leucine
Leucine caused a profound fall in blood sugar in the four patients, but had no comparable effect in normal subjects (Figure 7 ). Generally the blood sugar concentration in the patients dropped to about half the fasting value 30 to 45 minutes after all the test dose had been ingested, and In every specimen, in addition to the "true sugar," the "apparent sugar" was determined by omitting the treatment with Biodeminrolit G, the difference giving a value for non-sugar reducing substances (N.S.R.) remaining after tungstic acid precipitation. In the normal subjects the concentration of N.S.R. was equivalent to 13.4 3.3 (S.D.) mg. of glucose per 100 ml. of blood (28 samples) . The values were constant, within experimental error, for any given individual over the 90 minutes of a blood sugar curve, and were unaffected by feeding casein, glucose, leucine or isovaleric acid, but they varied slightly from day to day, and more markedly from individual to individual.
Most of the fasting specimens of blood from cases 1, 2, 3, and 4 had values for N.S.R. that fell within the normal range. However feeding leucine caused a marked fall in N.S.R. in cases 1, 2, and 3 (from 13.5 to 5.5 mg. "glucose" per 100 ml. blood for case 1; from 15.5 to 3.5 and from 14 to 3 for case 2; from 16.5 to 6.5 for case 3), the minimum value occurring 10 or 15 minutes later than the minimum for the true glucose ( Figure 7 ) and the value returning to near normal in 90 minutes. In case 4 the fasting N.S.R. was equivalent to only 5 mg. glucose per 100 ml. blood and did not show any further fall on feeding leucine. Casein caused a similar but less marked drop in N.S.R. in cases 1, 2, and 4; case 3 was not fed casein. Gelatine, tyrosine and isovaleric acid had no effect on the N.S.R. in case 2. Feeding glucose had no effect at all on the N.S.R. in any of these cases nor did the injection of glucagon.
In another hypoglycemic child (not reported in detail, see Figure 4) (15, 16) , was 37 mg. per 100 ml., but by paper chromatography the glucose content was found to be 8.5 + 1 mg. per 100 ml. Earlier the same day her blood glucose was 20 mg. per 100 ml. by paper chromatography, but her apparent blood sugar was 60 mg. per 100 ml. by the method of Folin and Wu. No sugar other than glucose was detected in either specimen. There was never any detectable loss of glucose in the urine, either spontaneously or after feeding casein, in any of the patients. The other urinary sugars were normal. After case 4 had been fed glucose for a tolerance test, his urinary glucose reached 5 mg. per 100 ml., but this is still within normal limits.
The fasting blood concentrations of the different amino acids were normal in cases 1, 2, and 3 but somewhat higher than average in case 4 (two specimens), the relative proportions of the different amino acids were normal in all four. No explanation could be found, among the amino Tyrosine, which is almost absent from gelatine but composes 6.4 per cent of casein, was investi- gated first, but proved to have no effect on the blood sugar concentration. L-leucine was tried next and had a most dramatic effect. The extent of the hypoglycemic response varied with the dose of leucine; the effects of test doses of casein and gelatine could be fully accounted for by their leucine content. Other amino acids are being investigated but the results obtained with leucine seemed to merit publication at this time.
A sufficient number of normal individuals were tested with casein and leucine to indicate that these substances did not produce a fall in blood sugar under fasting conditions. Very little work has been published in which human blood sugar concentrations have been measured at intervals after administering single amino acids. Manzini and Arullani (25) have reported that 50 to 80 mg. of leucine injected subcutaneously into normal fasting men causes a fall of about 25 per cent in blood sugar concentration; this may be contrasted with the results of our feeding experiments. Schenck (26) found that glycine in 40 to 50 g. oral doses caused a moderate reduction in the blood sugar concentrations of normal and diabetic adults (from 102 to 72 and from 256 to 161 mg. per 100 ml., respectively). Carballeira, Elrick, Mackenzie, and Browne (27) infused a mixture of ten amino acids (including L-leucine) intravenously into four normal fasting men and observed a slight drop (from 70 to 60 and from 76 to 60 mg. per 100 ml., respectively) in the blood sugar concentration in two of them 32 minutes after the mid-point of the infusion. A slight rise occurred in a third case and there was no change in the blood sugar of a fourth case.
There is considerable evidence in the literature suggesting an inter-relationship between the blood levels of amino acids, glucose, insulin, and adrenaline. Feeding glucose to normal men causes a drop in blood amino acid levels, leucine being depressed more than the other amino acids (28, 29 (33) and others have produced considerable evidence that glycine and some other amino acids act by causing the release of adrenaline. Schenck, on the other hand, found that glycine depressed the blood sugar level (26, 37) , while others could find no effect (38, 39) . According to some workers (40, 41) feeding glycine produces an initial hyperglycemia caused by the release of adrenaline, followed by prolonged hypoglycemia, caused by release of insulin in response to the hyperglycemia, though the liver plays some obscure part in the hypoglycemia (41) . It is doubtful whether this explanation can account for all the results obtained by other workers. Manzini and Arullani (25, 35) found that leucine raised the blood sugar concentration of the rabbit but depressed that of man. The differences found by different workers for other amino acids may be partly explained by the use of different species.
A more relevant finding is that protein hydrolysates administered to humans simultaneously with glucose either intravenously (42) or orally (43) markedly reduce the height of the hyperglycemic curve that would result from administering the glucose alone, though the protein hydrolysate does not produce hypoglycemia in the fasting individual (43) . (Compare Figure 5 .) This may be compared with the finding of Chikano (39) that leucine, injected into rabbits, markedly reduced the hyperglycemia produced by injecting adrenaline or glucose, though it does not affect the fasting blood sugar level when given alone. However, Pollak (36) found that isovaleric acid had little or no effect on the glycemic curve in rabbits when fed with glucose.
For the four affected individuals considered here, but not for normal persons, leucine is a most potent drug, active when taken in comparatively low dosage. This effect must be distinguished from the toxic actions of the diamidines which cause hypoglycemia after initial hyperglycemia by depletion of liver glycogen stores (44, 45) . Since leucine is always present in the blood it may be partly responsible for the low fasting blood sugar levels of these patients. It remained to be decided whether leucine itself caused the hypoglycemic response or whether it was converted at an abnormally high rate to an active intermediate metabolite, possibly one not formed in normal individuals.
According to Coon (46) The blood sugar curve produced by the administration of leucine or its metabolite is almost identical with that produced by giving insulin to a normal individual for an "insulin tolerance test" as described by Wilkins (47) . In both tests the maximal drop in blood sugar concentration occurs at 30 to 45 minutes with a return to the fasting level in 60 to 90 minutes.
Tentatively we suggest that leucine or its metabolite, isovaleric acid, acts by one of two mechanisms: either (a) it may enhance the effect of circulating insulin on intracellular carbohydrate metabolism, or (b) it may cause an increased secretion of insulin by the islets of Langerhans. It should be possible, using present techniques, to differentiate the two possible modes of action, and work is proceeding on this. In normal humans or animals leucine (alone or in mixtures) causes a decrease in the hyperglycemic curve that follows administration of glucose; this can be explained as an enhancement of the effect of the insulin released in response to the hyperglycemia or, perhaps as the release of additional insulin. The second possibility is rendered less likely but not completely excluded by leucine having no hypoglycemic effect in fasting normal humans or animals; the blood insulin level is presumably so low under these conditions that any enhancing effect of leucine would be undetectable. Of the four patients who showed a hypoglycemic response to leucine while fasting, one has been shown to have an abnormally high blood insulin level, again supporting possibility (a) but not excluding (b). However, the failure of a fifth hypoglycemic child to show a marked hypoglycemic response to casein (Figure 4) suggests the possibility of two types of hypoglycemia.
We have no explanation of the changes observed in blood non-sugar reducing substances (N.S.R.). There can however be no doubt that these substances (generally considered to be mainly glutathione and erogthioneine) are closely bound up with the blood glucose. In diabetics the N.S.R. level is often abnormal (21, 48) . In three of the cases of hypoglycemia reported here the fasting N.S.R. has been, on occasion, well outside the normal range. Finally the fall and rise of the N.S.R. curve when leucine or casein is fed parallels, but lags a little behind, the fall and rise of the blood glucose curve. The most surprising features are the extraordinarily rapid change in the N.S.R. when leucine or casein is fed and the failure of the fasting N.S.R. to rise when glucose or glucagon is administered.
Idiopathic hypoglycemia of the type seen in cases 1, 2, and 3 can be diagnosed by feeding a test dose of casein (1.5 g. per kg.) or L-leucine (0.15 g. per kg.) to the fasting subject and noting the blood sugar level at frequent intervals for the next ninety minutes. Other amino acids may well cause a fall in blood glucose and one of us (W.A.C.) is now investigating this possibility.
It would not be practical or even wise to attempt to restrict the protein intake of growing children but the results suggest that in this particular type of hypoglycemia high protein feeds should be avoided. We have suggested that small amounts of carbohydrate be given thirty to forty minutes after the ingestion of a feed to offset the effect of the protein in lowering the blood sugar. The natural course of the disease leads to less frequent fits as the child gets older but permanent mental deterioration will set in early in life if many hypoglycemic fits occur. The prognosis is good if acute hypoglycemic episodes are avoided by these means.
SUMMARY
Protein, leucine, or isovaleric acid, fed to three members of a family with spontaneous idiopathic hypoglycemia, caused a marked fall in the fasting true blood sugar level. They had a similar effect in a fourth child with hypoglycemia due to islet cell hyperplasia, but had no effect in normal fasting individuals. In another case of spontaneous idiopathic hypoglycemia casein had a less marked effect.
High protein feeds produced more fits and lower blood sugar values in the affected family than did a low protein diet. The non-sugar reducing level was significantly outside the normal range in some blood samples from these patients and the apparent blood sugar level can be very misleading. The non-sugar reducing level fell nearly as fast as the true blood sugar level on feeding leucine or casein.
A casein test meal is advocated as a means of differentiating this type of hypoglycemia.
